NCT04696419

Brief Summary

The study aims to identify and quantify objective non-invasive measures of the immediate effect of contact with dogs in a standardized experimental setup. Employing a within-subject design, the study includes healthy participants that are exposed to three different levels of contact to a dog compared with a no-dog control condition while obtaining measures of both physiological, behavioral, and psychological effects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2020

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

October 9, 2020

Completed
3 months until next milestone

First Posted

Study publicly available on registry

January 6, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2021

Completed
Last Updated

November 10, 2021

Status Verified

October 1, 2020

Enrollment Period

1 year

First QC Date

October 9, 2020

Last Update Submit

November 9, 2021

Conditions

Keywords

Animal-assisted therapyNon-invasive measureHuman-animal contact

Outcome Measures

Primary Outcomes (53)

  • Physiological measure, heart rate

    The test person wears self-adhesive electrodes and the heart rate is measured non-invasively,

    Measured continuously throughout the total test period of 190 minutes (through the pre-intervention period, the four test situations and all resting periods)

  • Physiological measure, blood pressure

    Blood pressure is measured manually with a blood pressure monitor with a blood pressure cuff

    Baseline: Measured at onset of the 30 minute pre-intervention period preceeding the first of the four test situations (t=0 minutes)

  • Physiological measure, blood pressure

    Blood pressure is measured manually with a blood pressure monitor with a blood pressure cuff

    Test periods: Measured immediately preceeding the first test situation: t=30 minutes

  • Physiological measure, blood pressure

    Blood pressure is measured manually with a blood pressure monitor with a blood pressure cuff

    Test periods: Measured immediately following the first test situation: t= 40 minutes

  • Physiological measure, blood pressure

    Blood pressure is measured manually with a blood pressure monitor with a blood pressure cuff

    Test periods: Measured immediately preceeding the second test situation: t= 70 minutes

  • Physiological measure, blood pressure

    Blood pressure is measured manually with a blood pressure monitor with a blood pressure cuff

    Test periods: Measured immediately following the second test situation: t= 80 minutes

  • Physiological measure, blood pressure

    Blood pressure is measured manually with a blood pressure monitor with a blood pressure cuff

    Test periods: Measured immediately preceeding the third test situation: t= 110 minutes.

  • Physiological measure, blood pressure

    Blood pressure is measured manually with a blood pressure monitor with a blood pressure cuff

    Test periods: Measured immediately following the third test situation: t= 120 minutes.

  • Physiological measure, blood pressure

    Blood pressure is measured manually with a blood pressure monitor with a blood pressure cuff

    Test periods: Measured immediately preceeding the fourth test situation: t= 150 minutes.

  • Physiological measure, blood pressure

    Blood pressure is measured manually with a blood pressure monitor with a blood pressure cuff

    Test periods: Measured immediately following the fourth test situation: t=160 minutes.

  • Physiological measure, blood pressure

    Blood pressure is measured manually with a blood pressure monitor with a blood pressure cuff

    After the last resting period: Measured at the end of the last resting period, following the last of the four test situations: t= 190 minutes

  • Physiological measure, heart rate variablility

    Heart rate variability is calculated from heart rate data

    Measured continuously throughout the total test period of 190 minutes (through the pre-intervention period, the four test situations and all resting periods)

  • Physiological measure, galvanic skin response

    The test person is fitted with electrodes on two fingers and galvanic skin response is measured non-invasively,

    Measured continuously throughout the total test period of 190 minutes (through the pre-intervention period, the four test situations and all resting periods)

  • Salivary cortisol

    Saliva is obtained from the testperson with a cotton swab which is chewed for one minute

    Baseline: Measured at onset of the 30 minute pre-intervention period preceeding the first of the four test situations (t=0 minutes)

  • Salivary cortisol

    Saliva is obtained from the testperson with a cotton swab which is chewed for one minute

    Test periods: Measured immediately preceeding the first test situation: t=30 minutes.

  • Salivary cortisol

    Saliva is obtained from the testperson with a cotton swab which is chewed for one minute

    Test periods: Measured immediately following the first test situation: t=40 minutes.

  • Salivary cortisol

    Saliva is obtained from the testperson with a cotton swab which is chewed for one minute

    Test periods: Measured immediately preceeding the second test situation: t=70 minutes.

  • Salivary cortisol

    Saliva is obtained from the testperson with a cotton swab which is chewed for one minute

    Test periods: Measured immediately following the second test situation: t=80 minutes.

  • Salivary cortisol

    Saliva is obtained from the testperson with a cotton swab which is chewed for one minute

    Test periods: Measured immediately preceeding the third test situation: t=110 minutes.

  • Salivary cortisol

    Saliva is obtained from the testperson with a cotton swab which is chewed for one minute

    Test periods: Measured immediately following the third test situation: t=120 minutes.

  • Salivary cortisol

    Saliva is obtained from the testperson with a cotton swab which is chewed for one minute

    Test periods: Measured immediately preceeding the fourth test situation: t=150 minutes.

  • Salivary cortisol

    Saliva is obtained from the testperson with a cotton swab which is chewed for one minute

    Test periods: Measured immediately following the fourth test situation: t=160 minutes.

  • Salivary cortisol

    Saliva is obtained from the testperson with a cotton swab which is chewed for one minute

    After the last resting period: Measured at the end of the last resting period, following the last of the four test situations; t= 190 minutes

  • Salivary oxytocin

    Saliva is obtained from the testperson with a cotton swab which is chewed for one minute

    Baseline: Measured at onset of the 30 minute pre-intervention period preceeding the first of the four test situations (t=0 minutes)

  • Salivary oxytocin

    Saliva is obtained from the testperson with a cotton swab which is chewed for one minute

    Test periods: Measured immediately preceeding the first test situation: t=30 minutes.

  • Salivary oxytocin

    Saliva is obtained from the testperson with a cotton swab which is chewed for one minute

    Test periods: Measured immediately following the first test situation: t= 40 minutes.

  • Salivary oxytocin

    Saliva is obtained from the testperson with a cotton swab which is chewed for one minute

    Test periods: Measured immediately preceeding the second test situation: t= 70 minutes.

  • Salivary oxytocin

    Saliva is obtained from the testperson with a cotton swab which is chewed for one minute

    Test periods: Measured immediately following the second test situation: t= 80 minutes.

  • Salivary oxytocin

    Saliva is obtained from the testperson with a cotton swab which is chewed for one minute

    Test periods: Measured immediately preceeding the third test situation: t= 110 minutes.

  • Salivary oxytocin

    Saliva is obtained from the testperson with a cotton swab which is chewed for one minute

    Test periods: Measured immediately following the third test situation: t= 120 minutes.

  • Salivary oxytocin

    Saliva is obtained from the testperson with a cotton swab which is chewed for one minute

    Test periods: Measured immediately preceeding the fourth test situation: 150 minutes.

  • Salivary oxytocin

    Saliva is obtained from the testperson with a cotton swab which is chewed for one minute

    Test periods: Measured immediately following the fourth test situation: t=160 minutes.

  • Salivary oxytocin

    Saliva is obtained from the testperson with a cotton swab which is chewed for one minute

    After the last resting period: Measured at the end of the last resting period, following the last of the four test situations; t= 190 minutes

  • Visual analogue scales measuring expected psychological and physiological effects of the test day including, including all four test situations

    Test persons fill in a visual analoque scale. Minimum value -100 (very negative effect) and maximum value 100 (very positive effect), and 0 being neutral.

    Baseline: Measured at onset of the 30 minute pre-intervention period preceeding the first of the four test situations (t=0 minutes)

  • Visual analogue scales measuring expected psychological and physiological effects of each of the four test situations

    Test persons fill in a visual analoque scale. Minimum value -100 (very negative effect) and maximum value 100 (very positive effect), and 0 being neutral.

    Test periods: Measured immediately preceeding the first test situation: t=30 minutes

  • Visual analogue scales measuring expected psychological and physiological effects of each of the four test situations

    Test persons fill in a visual analoque scale. Minimum value -100 (very negative effect) and maximum value 100 (very positive effect), and 0 being neutral.

    Test periods: Measured immediately preceeding the second test situation: t= 70minutes

  • Visual analogue scales measuring expected psychological and physiological effects of each of the four test situations

    Test persons fill in a visual analoque scale. Minimum value -100 (very negative effect) and maximum value 100 (very positive effect), and 0 being neutral.

    Test periods: Measured immediately preceeding the third test situation: t= 110 minutes

  • Visual analogue scales measuring expected psychological and physiological effects of each of the four test situations

    Test persons fill in a visual analoque scale. Minimum value -100 (very negative effect) and maximum value 100 (very positive effect), and 0 being neutral.

    Test periods: Measured immediately preceeding the fourth test situation: t=150 minutes

  • Visual analogue scales measuring perceived psychological and physiological effects of each of the four test situations

    Test persons fill in a visual analoque scale. Minimum value -100 (very negative effect) and maximum value 100 (very positive effect), and 0 being neutral.

    Test periods: Measured immediately following the first test situations: t=40 minutes

  • Visual analogue scales measuring perceived psychological and physiological effects of each of the four test situations

    Test persons fill in a visual analoque scale. Minimum value -100 (very negative effect) and maximum value 100 (very positive effect), and 0 being neutral.

    Test periods: Measured immediately following the second test situation: t= 80 minutes

  • Visual analogue scales measuring perceived psychological and physiological effects of each of the four test situations

    Test persons fill in a visual analoque scale. Minimum value -100 (very negative effect) and maximum value 100 (very positive effect), and 0 being neutral.

    Test periods: Measured immediately following the third test situation: t=120 minutes

  • Visual analogue scales measuring perceived psychological and physiological effects of each of the four test situations

    Test persons fill in a visual analoque scale. Minimum value -100 (very negative effect) and maximum value 100 (very positive effect), and 0 being neutral.

    Test periods: Measured immediately following the fourth test situation: t= 160 minutes

  • Visual analogue scales measuring perceived psychological and physiological effects of of the test day including, including all four test situations

    Test persons fill in a visual analoque scale. Minimum value -100 (very negative effect) and maximum value 100 (very positive effect), and 0 being neutral.

    After last resting period: Measured at the end of the last resting period, following the last of the four test situations, t=190 minutes

  • The State-Trait Anxiety Inventory (STAI)

    State anxiety is measured with the STAI-scale (minimum score= 20, maximum score= 80, and a lower score indicates a high anxiety level)

    Baseline: Measured at onset of the 30 minute pre-intervention period preceeding the first of the four test situations (t=0 minutes)

  • The State-Trait Anxiety Inventory (STAI)

    State anxiety is measured with the STAI-scale (minimum score= 20, maximum score= 80, and a lower score indicates a high anxiety level)

    Test periods: Measured immediately following the first test situation: t=40 minutes

  • The State-Trait Anxiety Inventory (STAI)

    State anxiety is measured with the STAI-scale (minimum score= 20, maximum score= 80, and a lower score indicates a high anxiety level)

    Test periods: Measured immediately following the second test situation: t= 80 minutes

  • The State-Trait Anxiety Inventory (STAI)

    State anxiety is measured with the STAI-scale (minimum score= 20, maximum score= 80, and a lower score indicates a high anxiety level)

    Test periods: Measured immediately following the third test situation: t= 120 minutes

  • The State-Trait Anxiety Inventory (STAI)

    State anxiety is measured with the STAI-scale (minimum score= 20, maximum score= 80, and a lower score indicates a high anxiety level)

    Test periods: Measured immediately following the fourth test situation: t= 160 minutes

  • The Positive and Negative Affect Schedule (PANAS)

    Positive and negative affect is measured with the PANAS scale, where the person scores whether or not they experience each of 20 emotions on a 5-step scale from "very little /not at all" to "extremely much". The emotions differ in valens.

    Baseline: Measured at onset of the 30 minute pre-intervention period preceeding the first of the four test situations (t=0 minutes)

  • The Positive and Negative Affect Schedule (PANAS)

    Positive and negative affect is measured with the PANAS scale, where the person scores whether or not they experience each of 20 emotions on a 5-step scale from "very little /not at all" to "extremely much". The emotions differ in valens.

    Test periods: Measured immediately following the first test situation: t= 40 minutes

  • The Positive and Negative Affect Schedule (PANAS)

    Positive and negative affect is measured with the PANAS scale, where the person scores whether or not they experience each of 20 emotions on a 5-step scale from "very little /not at all" to "extremely much". The emotions differ in valens.

    Test periods: Measured immediately following the second test situation: t= 80 minutes

  • The Positive and Negative Affect Schedule (PANAS)

    Positive and negative affect is measured with the PANAS scale, where the person scores whether or not they experience each of 20 emotions on a 5-step scale from "very little /not at all" to "extremely much". The emotions differ in valens.

    Test periods: Measured immediately following the third test situation: t=120 minutes

  • The Positive and Negative Affect Schedule (PANAS)

    Positive and negative affect is measured with the PANAS scale, where the person scores whether or not they experience each of 20 emotions on a 5-step scale from "very little /not at all" to "extremely much". The emotions differ in valens.

    Test periods: Measured immediately following the fourth test situation: t=160 minutes

Secondary Outcomes (2)

  • Quantitative behavioural measures - frequencies of behavioural elements

    Measured continuously throughout the total test period of 190 minutes (through the pre-intervention period, the four test situations and all resting periods)

  • Quantitative behavioural measures - duration of behavioural elements

    Measured continuously throughout the total test period of 190 minutes (through the pre-intervention period, the four test situations and all resting periods)

Study Arms (1)

ANIMAL CONTACT 1

OTHER

Only one arm - within-subject design

Other: Different intensities of contact to dogs

Interventions

Each subject is exposed to four test situations of 10 minutes. Three situations with increasing intensity of dog contact, and one control test situation with no contact to a dog. The order of the test situations is random and with 30 minute washout in-between

ANIMAL CONTACT 1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Normal cognitive functioning and physical movement
  • Ability to speak and read Danish

You may not qualify if:

  • Known medical, psychiatric or neurological disease
  • Use of psychotropic medications
  • Frequent use of pain medication
  • Use of illegal psychotropic drugs
  • Known allergies to dogs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aarhus University

Tjele, DK-8830, Denmark

Location

Related Publications (1)

  • Fuglsang-Damgaard LH, Lunde SJ, Christensen JW, Vase L, Videbech PB, Thodberg K. Human physiological responses to different types of human-dog interactions: A randomised crossover study. Complement Ther Clin Pract. 2024 Nov;57:101899. doi: 10.1016/j.ctcp.2024.101899. Epub 2024 Aug 26.

Study Officials

  • Karen Thodberg

    Senior researcher

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: Randomised within-subject design. Each subject is exposed to three different levels of contact with a dog and a control situation in randomised order.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 9, 2020

First Posted

January 6, 2021

Study Start

October 1, 2020

Primary Completion

October 1, 2021

Study Completion

October 1, 2021

Last Updated

November 10, 2021

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share

Locations